Lv714
3870 积分 2023-02-01 加入
Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using Tetrahymena group I intron ribozyme
3个月前
已完结
A flexible, efficient, and scalable platform to produce circular RNAs as new therapeutics
3个月前
已完结
Clinical delivery of circular RNA: Lessons learned from RNA drug development
3个月前
已完结
Messenger RNA chromatographic purification: advances and challenges
3个月前
已完结
Intratumoral Delivered Novel Circular mRNA Encoding Cytokines for Immune Modulation and Cancer Therapy
3个月前
已完结
皖公网安备34019202002308
